Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Drug Shortage Prevention Plan Includes Measures For Brexit

Executive Summary

Brexit, pediatric formulations and multilingual packages are among the topics addressed in a newly published action plan on improving the availability of medicines authorized in the EU.

You may also be interested in...



Pharma Slammed Over European Hospital Drug Shortages

A new survey has found that more than 90% of European hospital pharmacies see medicine shortages as an ongoing problem, and that more than a third experience shortages on a weekly basis. In many cases the pharmacists blame manufacturers for failing to notify them of impending shortages. 

EMA And National Agency Heads Join Forces On Medicines Availability and Big Data

The European Medicines Agency and the EU Heads of Medicines Agencies network are working together on a broad range of subjects, from big data to the availability of medicines… and of course, Brexit.

EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions

After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS123779

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel